文献速递间质性肺疾病

Flt3L/肺树突状细胞轴参与肺纤维化调控

The FMS-like tyrosine kinase-3 ligand/lung dendritic cell axis contributes to regulation of pulmonary fibrosis.
PubMed 文献 · Thorax · 2019-05-10

该研究在腺病毒转染活性TGF-β1的小鼠肺纤维化模型中,发现已形成的肺纤维化伴随血清Flt3L水平升高及肺内CD11b阳性树突状细胞积聚;特发性肺纤维化患者血清和肺组织Flt3L蛋白也升高,肺树突状细胞在胸膜下肺组织积聚。缺乏Flt3L的小鼠肺树突状细胞显著减少、肺纤维化加重、肺功能降低,而给予重组Flt3L可抑制上述改变;治疗性Flt3L增加CD11b阳性树突状细胞并改善肺纤维化,CD103阳性树突状细胞亚群未参与肺纤维化发生。

要点

  • 肺纤维化时Flt3L及肺CD11b阳性树突状细胞升高,患者与小鼠一致。
  • 缺乏Flt3L加重小鼠肺纤维化并降低肺功能。
  • 重组Flt3L可增加CD11b阳性树突状细胞并改善肺纤维化。

核心结论

  • Flt3L蛋白和肺树突状细胞数量在 mice 和 humans 肺纤维化发生过程中上调,增加肺CD11b阳性树突状细胞动员可限制小鼠肺纤维化严重程度。

研究设计与样本

  • 研究采用腺病毒基因转移活性TGF-β1的小鼠肺纤维化模型,并检测特发性肺纤维化患者血清、肺组织及胸膜下肺组织标本。

主要发现

  • 已形成的肺纤维化伴随血清Flt3L水平升高及肺内CD11b阳性树突状细胞积聚。
  • 特发性肺纤维化患者血清和肺组织Flt3L蛋白水平升高,肺树突状细胞在胸膜下肺组织积聚。
  • 缺乏Flt3L的小鼠肺树突状细胞显著减少,肺纤维化加重,肺功能降低,给予重组Flt3L可抑制上述改变。
  • 治疗性Flt3L增加CD11b阳性树突状细胞并改善野生型小鼠肺纤维化。
  • CD11b阳性树突状细胞RNA测序显示细胞外基质降解酶和基质金属蛋白酶基因簇差异表达基因显著富集,CD103阳性树突状细胞亚群未参与肺纤维化发生。

临床怎么用

  • Flt3L/肺CD11b阳性树突状细胞轴可能作为肺纤维化免疫治疗的新靶点,但尚需临床研究验证。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

RATIONALE: Dendritic cells (DC) accumulate in the lungs of patients with idiopathic lung fibrosis, but their pathogenetic relevance is poorly defined. OBJECTIVES: To assess the role of the FMS-like tyrosine kinase-3 ligand (Flt3L)-lung dendritic cell axis in lung fibrosis. MEASUREMENTS AND MAIN RESULTS: We demonstrate in a model of adenoviral gene transfer of active TGF-β1 that established lung fibrosis was accompanied by elevated serum Flt3L levels and subsequent accumulation of CD11bpos DC in the lungs of mice. Patients with idiopathic pulmonary fibrosis also demonstrated increased levels of Flt3L protein in serum and lung tissue and accumulation of lung DC in explant subpleural lung tissue specimen. Mice lacking Flt3L showed significantly reduced lung DC along with worsened lung fibrosis and reduced lung function relative to wild-type (WT) mice, which could be inhibited by administration of recombinant Flt3L. Moreover, therapeutic Flt3L increased numbers of CD11bpos DC and improved lung fibrosis in WT mice exposed to AdTGF-β1. In this line, RNA-sequencing analysis of CD11bpos DC revealed significantly enriched differentially expressed genes within extracellular matrix degrading enzyme and matrix metalloprotease gene clusters. In contrast, the CD103pos DC subset did not appear to be involved in pulmonary fibrogenesis. CONCLUSIONS: We show that Flt3L protein and numbers of lung DC are upregulated in mice and humans during pulmonary fibrogenesis, and increased mobilisation of lung CD11bpos DC limits the severity of lung fibrosis in mice. The current study helps to inform the development of DC-based immunotherapy as a novel intervention against lung fibrosis in humans.

来源:Thorax,查看原文。版权归原作者所有。

引用

  1. Tort Tarrés M, Aschenbrenner F, Maus R, et al. The FMS-like tyrosine kinase-3 ligand/lung dendritic cell axis contributes to regulation of pulmonary fibrosis. Thorax. 2019. PMID: 31076499. doi:10.1136/thoraxjnl-2018-212603

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。